Heavy ion linac as a high current proton beam injector von Barth, Winfried, Adonin, Aleksey, Appel, Sabrina, Gerhard, Peter, Heilmann, Manuel, Heymach, Frank, Hollinger, Ralph, Vinzenz, Wolfgang, Vormann, Hartmut, Yaramyshev, Stepan

Volltext

Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic Targets von Ferrarotto, Renata, Mitani, Yoshitsugu, McGrail, Daniel J, Li, Kaiyi, Karpinets, Tatiana V, Bell, Diana, Frank, Steven J, Song, Xingzhi, Kupferman, Michael E, Liu, Bin, Lee, J Jack, Glisson, Bonnie S, Zhang, Jianhua, Aster, Jon C, Lin, Shiaw-Yih, Futreal, P Andrew, Heymach, John V, El-Naggar, Adel K

Volltext

T-Cell Receptor Repertoire Sequencing in the Era of Cancer Immunotherapy von Frank, Meredith L, Lu, Kaylene, Erdogan, Can, Han, Yi, Hu, Jian, Wang, Tao, Heymach, John V, Zhang, Jianjun, Reuben, Alexandre

Volltext

Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer von Liao, Zhongxing, Lee, J Jack, Komaki, Ritsuko, Gomez, Daniel R, O'Reilly, Michael S, Fossella, Frank V, Blumenschein, Jr, George R, Heymach, John V, Vaporciyan, Ara A, Swisher, Stephen G, Allen, Pamela K, Choi, Noah Chan, DeLaney, Thomas F, Hahn, Stephen M, Cox, James D, Lu, Charles S, Mohan, Radhe

Volltext

Poziotinib for Patients With HER2 Exon 20 Mutant Non-Small-Cell Lung Cancer: Results From a Phase II Trial von Elamin, Yasir Y, Robichaux, Jacqulyne P, Carter, Brett W, Altan, Mehmet, Gibbons, Don L, Fossella, Frank V, Lam, Vincent K, Patel, Anisha B, Negrao, Marcelo V, Le, Xiuning, Mott, Frank E, Zhang, Jianjun, Feng, Lei, Blumenschein, Jr, George, Tsao, Anne S, Heymach, John V

Volltext

Response rates to single-agent chemotherapy after exposure to immune checkpoint inhibitors in advanced non-small cell lung cancer von Schvartsman, Gustavo, Peng, S. Andrew, Bis, Giorgios, Lee, J. Jack, Benveniste, Marcelo F.K., Zhang, Jianjun, Roarty, Emily B., Lacerda, Lara, Swisher, Stephen, Heymach, John V., Fossella, Frank V., William, William N.

Volltext

Poziotinib for EGFR exon 20-mutant NSCLC: Clinical efficacy, resistance mechanisms, and impact of insertion location on drug sensitivity von Elamin, Yasir Y., Robichaux, Jacqulyne P., Carter, Brett W., Altan, Mehmet, Tran, Hai, Gibbons, Don L., Heeke, Simon, Fossella, Frank V., Lam, Vincent K., Le, Xiuning, Negrao, Marcelo V., Nilsson, Monique B., Patel, Anisha, Vijayan, R.S.K., Cross, Jason B., Zhang, Jianjun, Byers, Lauren A., Lu, Charles, Cascone, Tina, Feng, Lei, Luthra, Rajyalakshmi, San Lucas, Francis A., Mantha, Geeta, Routbort, Mark, Blumenschein, George, Tsao, Anne S., Heymach, John V.

Volltext

A pan-cancer proteomic perspective on The Cancer Genome Atlas von Akbani, Rehan, Ng, Patrick Kwok Shing, Werner, Henrica M. J., Shahmoradgoli, Maria, Zhang, Fan, Ju, Zhenlin, Liu, Wenbin, Yang, Ji-Yeon, Yoshihara, Kosuke, Li, Jun, Ling, Shiyun, Seviour, Elena G., Ram, Prahlad T., Minna, John D., Diao, Lixia, Tong, Pan, Heymach, John V., Hill, Steven M., Dondelinger, Frank, Städler, Nicolas, Byers, Lauren A., Meric-Bernstam, Funda, Weinstein, John N., Broom, Bradley M., Verhaak, Roeland G. W., Liang, Han, Mukherjee, Sach, Lu, Yiling, Mills, Gordon B.

Volltext

High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: Results of a phase II trial von Patel, Roshal R., He, Kewen, Barsoumian, Hampartsoum B., Chang, Joe Y., Tang, Chad, Verma, Vivek, Comeaux, Nathan, Chun, Stephen G., Gandhi, Saumil, Truong, Mylene T., Erasmus, Jeremy J., Hong, David S., Lee, Percy P., Ning, Matthew S., Nguyen, Quynh-Nhu, Heymach, John V., Altan, Mehmet, Blumenschein, George, Fossella, Frank V., Sezen, Duygu, Chen, Dawei, Carter, Brett W., Davies, Michael A., Glitza, Isabella C., Diab, Adi, Ferrarotto, Renata, Cabanillas, Maria E., Yuan, Ying, Shah, Shalin J., Parra, Edwin R., Sun, Baohua, Cortez, Maria Angelica, Welsh, James W.

Volltext

Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, ran... von Chang, Joe Y, Lin, Steven H, Dong, Wenli, Liao, Zhongxing, Gandhi, Saumil J, Gay, Carl M, Zhang, Jianjun, Chun, Stephen G, Elamin, Yasir Y, Fossella, Frank V, Blumenschein, George, Cascone, Tina, Le, Xiuning, Pozadzides, Jenny V, Tsao, Anne, Verma, Vivek, Welsh, James W, Chen, Aileen B, Altan, Mehmet, Mehran, Reza J, Vaporciyan, Ara A, Swisher, Stephen G, Balter, Peter A, Fujimoto, Junya, Wistuba, Ignacio I, Feng, Lei, Lee, J Jack, Heymach, John V

Volltext

The BATTLE trial: personalizing therapy for lung cancer von Kim, Edward S, Herbst, Roy S, Wistuba, Ignacio I, Lee, J Jack, Blumenschein, Jr, George R, Tsao, Anne, Stewart, David J, Hicks, Marshall E, Erasmus, Jr, Jeremy, Gupta, Sanjay, Alden, Christine M, Liu, Suyu, Tang, Ximing, Khuri, Fadlo R, Tran, Hai T, Johnson, Bruce E, Heymach, John V, Mao, Li, Fossella, Frank, Kies, Merrill S, Papadimitrakopoulou, Vassiliki, Davis, Suzanne E, Lippman, Scott M, Hong, Waun K

Volltext

Pathomic Features Reveal Immune and Molecular Evolution From Lung Preneoplasia to Invasive Adenocarcinoma von Chen, Pingjun, Rojas, Frank R., Hu, Xin, Serrano, Alejandra, Zhu, Bo, Chen, Hong, Hong, Lingzhi, Bandyoyadhyay, Rukhmini, Aminu, Muhammad, Kalhor, Neda, Lee, J. Jack, El Hussein, Siba, Khoury, Joseph D., Pass, Harvey I., Moreira, Andre L., Velcheti, Vamsidhar, Sterman, Daniel H., Fukuoka, Junya, Tabata, Kazuhiro, Su, Dan, Ying, Lisha, Gibbons, Don L., Heymach, John V., Wistuba, Ignacio I., Fujimoto, Junya, Solis Soto, Luisa M., Zhang, Jianjun, Wu, Jia

Volltext

A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel, and Nintedanib for Resectable Non-Small Cell Lung Cancer von Cascone, Tina, Sepesi, Boris, Lin, Heather Y, Kalhor, Neda, Parra, Edwin R, Jiang, Mei, Godoy, Myrna C B, Zhang, Jianjun, Fossella, Frank V, Tsao, Anne S, Lam, Vincent K, Lu, Charles, Mott, Frank E, Simon, George R, Antonoff, Mara B, Mehran, Reza J, Rice, David C, Behrens, Carmen, Weissferdt, Annikka, Moran, Cesar, Vaporciyan, Ara A, Lee, J Jack, Swisher, Stephen G, Gibbons, Don L, Wistuba, Ignacio I, William, Jr, William N, Heymach, John V

Volltext

Toxicity and Survival After Intensity-Modulated Proton Therapy Versus Passive Scattering Proton Therapy for NSCLC von Gjyshi, Olsi, Xu, Ting, Elhammali, Adnan, Boyce-Fappiano, David, Chun, Stephen G., Gandhi, Saumil, Lee, Percy, Chen, Aileen B., Lin, Steven H., Chang, Joe Y., Tsao, Anne, Gay, Carl M., Zhu, X. Ronald, Zhang, Xiaodong, Heymach, John V., Fossella, Frank V., Lu, Charles, Nguyen, Quynh-Nhu, Liao, Zhongxing

Volltext

Mutational Characteristics and Clinical Outcomes for Lung Adenocarcinoma With EGFR Germline Mutations von Pan, Kelsey, Owens, Jennifer, Elamin, Yasir, Lu, Charles, Routbort, Mark, Zhang, Jianjun, Fossella, Frank, Negrao, Marcelo V., Altan, Mehmet, Pozadzides, Jenny, Skoulidis, Ferdinandos, Tsao, Anne, Cascone, Tina, Heymach, John V., Ostrin, Edwin, Le, Xiuning

Volltext

Positron Emission Tomography/Computed Tomography-Guided Intensity-Modulated Radiotherapy for Limited-Stage Small-Cell Lung Cancer von Shirvani, Shervin M., M.D, Komaki, Ritsuko, M.D, Heymach, John V., M.D., Ph.D, Fossella, Frank V., M.D, Chang, Joe Y., M.D., Ph.D

Volltext

Programmed Death-Ligand 1 Heterogeneity and Its Impact on Benefit From Immune Checkpoint Inhibitors in NSCLC von Hong, Lingzhi, Negrao, Marcelo V., Dibaj, Seyedeh S., Chen, Runzhe, Reuben, Alexandre, Bohac, Jadi M., Liu, Xiaoke, Skoulidis, Ferdinandos, Gay, Carl M., Cascone, Tina, Mitchell, Kyle G., Tran, Hai T., Le, Xiuning, Byers, Lauren A., Sepesi, Boris, Altan, Mehmet, Elamin, Yasir Y., Fossella, Frank V., Kurie, Jonathan M., Lu, Charles, Mott, Frank E., Tsao, Anne S., Rinsurongkawong, Waree, Lewis, Jeff, Gibbons, Don L., Glisson, Bonnie S., Blumenschein, George R., Roarty, Emily B., Futreal, P. Andrew, Wistuba, Ignacio I., Roth, Jack A., Swisher, Stephen G., Papadimitrakopoulou, Vassiliki A., Heymach, John V., Lee, J. Jack, Simon, George R., Zhang, Jianjun

Volltext

Final efficacy outcomes of atezolizumab with chemoradiation for unresectable NSCLC: The phase II DETERRED trial von Liu, Yufei, Yao, Luyang, Kalhor, Neda, Carter, Brett W., Altan, Mehmet, Blumenschein, George, Byers, Lauren A., Fossella, Frank, Gibbons, Don L., Kurie, Jonathan M., Lu, Charles, Skoulidis, Ferdinandos, Chang, Joe Y., Liao, Zhongxing, Gomez, Daniel R., O'Reilly, Michael, Heymach, John V., Tsao, Anne S., Lin, Steven H.

Volltext

Phase II Trial of Concurrent Atezolizumab With Chemoradiation for Unresectable NSCLC von Lin, Steven H., Lin, Yan, Yao, Luyang, Kalhor, Neda, Carter, Brett W., Altan, Mehmet, Blumenschein, George, Byers, Lauren A., Fossella, Frank, Gibbons, Don L., Kurie, Jonathan M., Lu, Charles, Simon, George, Skoulidis, Ferdinandos, Chang, Joe Y., Jeter, Melenda D., Liao, Zhongxing, Gomez, Daniel R., O’Reilly, Michael, Papadimitrakopoulou, Vali, Thall, Peter, Heymach, John V., Tsao, Anne S.

Volltext

Induction Cisplatin Docetaxel Followed by Surgery and Erlotinib in Non-Small Cell Lung Cancer von Cascone, Tina, Gold, Kathryn A., Swisher, Stephen G., Liu, Diane D., Fossella, Frank V., Sepesi, Boris, Pataer, Apar, Weissferdt, Annikka, Kalhor, Neda, Vaporciyan, Ara A., Hofstetter, Wayne L., Wistuba, Ignacio I., Heymach, John V., Kim, Edward S., William, William N.

Volltext